Drori, D
Coronary and Peripheral Artery Disease GLP-1 RAs have shown mixed results in the management of CAD, particularly regarding MI outcomes
Interactions between the GLP-1 pathway and addictive drugs, such as nicotine, opioids, and psychostimulants, have been demonstrated in rodents (Figure 3), and these are reviewed in the following sections
138 Recommended treatments for MASLD, including lean MASLD, still emphasize lifestyle interventions such as diet and exercise for weight loss
While only 1 in 5 Americans said these medications have changed their view of what a healthy body looks like, for most, the changes were positive: 14% said they now see more body types as "healthy", while just 6% still viewed leanness as the standard
And until the medical establishment adopts better metrics, understanding exactly where you fall on the BMI scale is the first step toward accessing GLP-1 therapy